Cargando…
Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509065/ https://www.ncbi.nlm.nih.gov/pubmed/35970595 http://dx.doi.org/10.1097/CM9.0000000000002309 |
| _version_ | 1784797152803815424 |
|---|---|
| author | Qu, Fengjiang Wu, Di Liu, Yunjiang Gao, Wei Wang, Shu Wang, Siyuan Jin, Feng Chen, Bo Huang, Jian Sun, Shanshan Fan, Zhimin |
| author_facet | Qu, Fengjiang Wu, Di Liu, Yunjiang Gao, Wei Wang, Shu Wang, Siyuan Jin, Feng Chen, Bo Huang, Jian Sun, Shanshan Fan, Zhimin |
| author_sort | Qu, Fengjiang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9509065 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95090652022-09-26 Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) Qu, Fengjiang Wu, Di Liu, Yunjiang Gao, Wei Wang, Shu Wang, Siyuan Jin, Feng Chen, Bo Huang, Jian Sun, Shanshan Fan, Zhimin Chin Med J (Engl) Clinical Observation Lippincott Williams & Wilkins 2022-07-20 2022-08-11 /pmc/articles/PMC9509065/ /pubmed/35970595 http://dx.doi.org/10.1097/CM9.0000000000002309 Text en Copyright © 2022 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Clinical Observation Qu, Fengjiang Wu, Di Liu, Yunjiang Gao, Wei Wang, Shu Wang, Siyuan Jin, Feng Chen, Bo Huang, Jian Sun, Shanshan Fan, Zhimin Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_full | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_fullStr | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_full_unstemmed | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_short | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_sort | clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in china: a multicenter, single-arm, open validation trial (csbrs-024) |
| topic | Clinical Observation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509065/ https://www.ncbi.nlm.nih.gov/pubmed/35970595 http://dx.doi.org/10.1097/CM9.0000000000002309 |
| work_keys_str_mv | AT qufengjiang clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT wudi clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT liuyunjiang clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT gaowei clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT wangshu clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT wangsiyuan clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT jinfeng clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT chenbo clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT huangjian clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT sunshanshan clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT fanzhimin clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 |